KRAS and non-small cell lung carcinoma: For example, in mouse and human tumor tissues, Kras activation and Trp53 mutation deletion in the pancreas or lungs lead to pancreatic ductal adenocarcinoma (PDAC) or non-small-cell lung cancer (NSCLC).